HNRNPK and neoplasm: By targeting several proteins such as Tap 63, Heterogeneous Nuclear Ribonucleoprotein K (HNRPK), and Programmed Cell Death Protein 4 (PDCD4), miR-21 achieved inhibition of apoptotic pathways, hence further contributing to tumor cell proliferation (Chen et al., 2021).